annual CFO:
-$331.41M+$174.56M(+34.50%)Summary
- As of today (May 29, 2025), ASND annual cash flow from operations is -$331.41 million, with the most recent change of +$174.56 million (+34.50%) on December 31, 2024.
- During the last 3 years, ASND annual CFO has risen by +$162.74 million (+32.93%).
- ASND annual CFO is now -4054.70% below its all-time high of $8.38 million, reached on December 31, 2013.
Performance
ASND Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
N/ASummary
- ASND quarterly cash flow from operations is not available.
Performance
ASND quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CFO:
N/ASummary
- ASND TTM cash flow from operations is not available.
Performance
ASND TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ASND Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.5% | - | - |
| 3 y3 years | +32.9% | - | - |
| 5 y5 years | -68.3% | - | - |
ASND Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.6% | ||||
| 5 y | 5-year | -68.3% | +36.6% | ||||
| alltime | all time | -4054.7% | +36.6% |
ASND Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$331.41M(-34.5%) | -$90.53M(+38.2%) | -$331.41M(+16.6%) |
| Sep 2024 | - | -$65.49M(+0.7%) | -$284.24M(-19.7%) |
| Jun 2024 | - | -$65.05M(-41.0%) | -$354.04M(-22.8%) |
| Mar 2024 | - | -$110.34M(+154.5%) | -$458.38M(-9.4%) |
| Dec 2023 | -$505.97M(-3.2%) | -$43.35M(-68.0%) | -$505.97M(-19.5%) |
| Sep 2023 | - | -$135.30M(-20.1%) | -$628.75M(+8.7%) |
| Jun 2023 | - | -$169.39M(+7.3%) | -$578.27M(+8.3%) |
| Mar 2023 | - | -$157.93M(-4.9%) | -$533.93M(+2.1%) |
| Dec 2022 | -$522.76M(+5.8%) | -$166.14M(+95.9%) | -$522.76M(+3.8%) |
| Sep 2022 | - | -$84.81M(-32.2%) | -$503.74M(-4.7%) |
| Jun 2022 | - | -$125.05M(-14.8%) | -$528.76M(-2.5%) |
| Mar 2022 | - | -$146.76M(-0.2%) | -$542.56M(+9.8%) |
| Dec 2021 | -$494.15M(+59.3%) | -$147.11M(+33.9%) | -$494.15M(+11.0%) |
| Sep 2021 | - | -$109.84M(-20.9%) | -$445.24M(+8.2%) |
| Jun 2021 | - | -$138.85M(+41.2%) | -$411.42M(+22.9%) |
| Mar 2021 | - | -$98.35M(+0.2%) | -$334.77M(+7.9%) |
| Dec 2020 | -$310.12M(+57.5%) | -$98.20M(+29.2%) | -$310.12M(+15.7%) |
| Sep 2020 | - | -$76.01M(+22.2%) | -$267.99M(+3.9%) |
| Jun 2020 | - | -$62.20M(-15.6%) | -$257.87M(+28.0%) |
| Mar 2020 | - | -$73.70M(+31.4%) | -$201.53M(+2.3%) |
| Dec 2019 | -$196.96M | -$56.08M(-14.9%) | -$196.96M(+6.6%) |
| Sep 2019 | - | -$65.89M(+1024.7%) | -$184.73M(+8.0%) |
| Jun 2019 | - | -$5.86M(-91.5%) | -$171.01M(-9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$69.13M(+57.6%) | -$187.90M(+14.6%) |
| Dec 2018 | -$163.90M(+52.2%) | -$43.85M(-15.9%) | -$163.90M(+13.5%) |
| Sep 2018 | - | -$52.16M(+129.3%) | -$144.34M(+14.7%) |
| Jun 2018 | - | -$22.75M(-49.6%) | -$125.89M(-3.3%) |
| Mar 2018 | - | -$45.13M(+85.7%) | -$130.20M(+20.9%) |
| Dec 2017 | -$107.70M(+61.7%) | -$24.30M(-27.9%) | -$107.70M(+6.2%) |
| Sep 2017 | - | -$33.71M(+24.6%) | -$101.43M(+19.3%) |
| Jun 2017 | - | -$27.06M(+19.5%) | -$85.04M(+16.8%) |
| Mar 2017 | - | -$22.64M(+25.5%) | -$72.82M(+9.3%) |
| Dec 2016 | -$66.60M(+38.1%) | -$18.03M(+4.1%) | -$66.60M(+11.8%) |
| Sep 2016 | - | -$17.31M(+16.7%) | -$59.60M(+6.0%) |
| Jun 2016 | - | -$14.84M(-9.6%) | -$56.23M(-0.7%) |
| Mar 2016 | - | -$16.42M(+48.9%) | -$56.60M(+17.4%) |
| Dec 2015 | -$48.23M(+97.1%) | -$11.03M(-20.9%) | -$48.23M(+1.7%) |
| Sep 2015 | - | -$13.94M(-8.4%) | -$47.43M(+26.0%) |
| Jun 2015 | - | -$15.22M(+89.0%) | -$37.63M(+29.5%) |
| Mar 2015 | - | -$8.05M(-21.3%) | -$29.06M(+18.7%) |
| Dec 2014 | -$24.47M(-392.0%) | -$10.23M(+146.9%) | -$24.47M(+71.8%) |
| Sep 2014 | - | -$4.14M(-37.6%) | -$14.25M(+41.0%) |
| Jun 2014 | - | -$6.64M(+91.4%) | -$10.11M(+191.4%) |
| Mar 2014 | - | -$3.47M | -$3.47M |
| Dec 2013 | $8.38M(-1099.8%) | - | - |
| Dec 2012 | -$838.20K | - | - |
FAQ
- What is Ascendis Pharma A/S annual cash flow from operations?
- What is the all time high annual CFO for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual CFO year-on-year change?
- What is the all time high quarterly CFO for Ascendis Pharma A/S?
- What is the all time high TTM CFO for Ascendis Pharma A/S?
What is Ascendis Pharma A/S annual cash flow from operations?
The current annual CFO of ASND is -$331.41M
What is the all time high annual CFO for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash flow from operations is $8.38M
What is Ascendis Pharma A/S annual CFO year-on-year change?
Over the past year, ASND annual cash flow from operations has changed by +$174.56M (+34.50%)
What is the all time high quarterly CFO for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash flow from operations is -$3.47M
What is the all time high TTM CFO for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM cash flow from operations is -$3.47M